280 related articles for article (PubMed ID: 17162143)
1. Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.
McQueen MJ; Gerstein HC; Pogue J; Mann JF; Yusuf S
Am J Kidney Dis; 2006 Dec; 48(6):889-96. PubMed ID: 17162143
[TBL] [Abstract][Full Text] [Related]
2. Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study: immunonephelometry compared with high-performance liquid chromatography.
Polkinghorne KR; Su Q; Chadban SJ; Shaw JE; Zimmet PZ; Atkins RC
Am J Kidney Dis; 2006 Apr; 47(4):604-13. PubMed ID: 16564938
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators.
Gerstein HC; Mann JF; Pogue J; Dinneen SF; Hallé JP; Hoogwerf B; Joyce C; Rashkow A; Young J; Zinman B; Yusuf S
Diabetes Care; 2000 Apr; 23 Suppl 2():B35-9. PubMed ID: 10860189
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of nephelometric and high-performance liquid chromatography assays of urine albumin for mortality in a high-risk Aboriginal population.
Wang Z; Hoy WE; Nicol JL; Wang Z; Su Q; Atkins RC; Polkinghorne KR
Am J Kidney Dis; 2008 Oct; 52(4):672-82. PubMed ID: 18585832
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of immuno-unreactive intact albumin in urine of diabetic patients.
Comper WD; Osicka TM; Jerums G
Am J Kidney Dis; 2003 Feb; 41(2):336-42. PubMed ID: 12552494
[TBL] [Abstract][Full Text] [Related]
6. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography.
Baweja S; Kent A; Masterson R; Roberts S; McMahon LP
BJOG; 2011 Aug; 118(9):1126-32. PubMed ID: 21481153
[TBL] [Abstract][Full Text] [Related]
7. Performance characteristics of an HPLC assay for urinary albumin.
Owen WE; Roberts WL
Am J Clin Pathol; 2005 Aug; 124(2):219-25. PubMed ID: 16040292
[TBL] [Abstract][Full Text] [Related]
8. HPLC-detected albuminuria predicts mortality.
Magliano DJ; Polkinghorne KR; Barr EL; Su Q; Chadban SJ; Zimmet PZ; Shaw JE; Atkins RC
J Am Soc Nephrol; 2007 Dec; 18(12):3171-6. PubMed ID: 18003774
[TBL] [Abstract][Full Text] [Related]
9. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
Gerstein HC; Mann JF; Yi Q; Zinman B; Dinneen SF; Hoogwerf B; Hallé JP; Young J; Rashkow A; Joyce C; Nawaz S; Yusuf S;
JAMA; 2001 Jul; 286(4):421-6. PubMed ID: 11466120
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
[TBL] [Abstract][Full Text] [Related]
11. Hypertension-based clinical risk strategies for detecting microalbuminuria in diabetes.
Baskar V; Kamalakannan D; Kiberd B; Holland MR; Singh BM
QJM; 2005 Jun; 98(6):427-33. PubMed ID: 15879442
[TBL] [Abstract][Full Text] [Related]
12. A population-based screening for microalbuminuria among relatives of CKD patients: the Kidney Evaluation and Awareness Program in Sheffield (KEAPS).
Bello AK; Peters J; Wight J; de Zeeuw D; El Nahas M;
Am J Kidney Dis; 2008 Sep; 52(3):434-43. PubMed ID: 18725014
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for development of microalbuminuria in diabetic and nondiabetic normoalbuminuric hypertensives with high or very high cardiovascular risk - a twelve-month follow-up study.
Cotter J; Oliveira P; Cunha P; Polónia J
Nephron Clin Pract; 2009; 113(1):c8-15. PubMed ID: 19590230
[TBL] [Abstract][Full Text] [Related]
14. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Ghadanfar M; Weissbach N; Xiang Z; Armbrecht J; Pfeffer MA
Nephrol Dial Transplant; 2009 May; 24(5):1663-71. PubMed ID: 19145003
[TBL] [Abstract][Full Text] [Related]
16. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay.
Comper WD; Osicka TM; Clark M; MacIsaac RJ; Jerums G
Kidney Int; 2004 May; 65(5):1850-5. PubMed ID: 15086926
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of microalbuminuria with immunonephelometry and high performance liquid chromatography. Evaluation of new criteria].
Markó L; Molnár GA; Wagner Z; Koszegi T; Matus Z; Mohás M; Kuzma M; Szijártó IA; Wittmann I
Orv Hetil; 2008 Jan; 149(2):59-67. PubMed ID: 18093896
[TBL] [Abstract][Full Text] [Related]
18. Urinary albumin and cardiovascular profile in the middle-aged population.
Cirillo M; Lombardi C; Bilancio G; Chiricone D; Stellato D; De Santo NG
Semin Nephrol; 2005 Nov; 25(6):367-71. PubMed ID: 16298257
[TBL] [Abstract][Full Text] [Related]
19. Microalbuminuria and uric acid in healthy subjects.
Bellomo G; Berardi P; Saronio P; Verdura C; Esposito A; Laureti A; Venanzi S; Timio F; Timio M
J Nephrol; 2006; 19(4):458-64. PubMed ID: 17048203
[TBL] [Abstract][Full Text] [Related]
20. Use of albumin creatinine ratio and urine albumin concentration as a screening test for albuminuria in an Indo-Asian population.
Jafar TH; Chaturvedi N; Hatcher J; Levey AS
Nephrol Dial Transplant; 2007 Aug; 22(8):2194-200. PubMed ID: 17405790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
